Samraat S. Raha insider trades

Open-market stock purchases and sales by Samraat S. Raha, President and CEO at Myriad Genetics Inc, from SEC Form 4 filings since May 15, 2018.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +15%.

Recent trades

DateStockTradeValue
Jun 11, 2026MYGN Myriad Genetics IncBought (not open market)$13.9K
Mar 14, 2026MYGN Myriad Genetics IncSold (not open market)$50.4K
Mar 13, 2026MYGN Myriad Genetics IncSold (not open market)$169K
Mar 12, 2026MYGN Myriad Genetics IncBought (not open market)—
Mar 9, 2026MYGN Myriad Genetics IncBought$200K
Dec 11, 2025MYGN Myriad Genetics IncSold (not open market)$216K

Companies traded

  • MYGN Myriad Genetics Inc: 1 buy, last Jun 11, 2026
  • A Agilent Technologies, Inc: 1 sale, last Nov 17, 2023

Get free alerts when Samraat S. Raha files a new trade →